Skin Care Firms Get External Analgesic Treatment In FDA Warning Letters

Firms marketed products with label and other claims rendering them drugs but containing ingredients and label indications not part of OTC external analgesic TFM, recent warning letters say. Each firm also advised about GMP problems based on findings from Office of Regulatory Affairs' inspections and asked to hire regulatory consultants and provide detailed CAPAs.